The Center for Alzheimer's and Neurodegenerative Diseases at UT Southwestern. Discovering mechanism-based diagnosis and therapy.

Dallas, Texas, USA
Joined June 2021
We’ll be at #BMES2026 in Orlando this week! Stop by Booth #911 to meet representatives from @UTSWGradSchool and learn about graduate education, biomedical engineering research, and training opportunities at UTSW. Hope to see you there! 👋 #UTSW @BMESociety
5
4
255
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
8
433
Anila D'Mello, Ph.D., received an NIH grant to study the neural basis of semantic language difficulties in autism spectrum disorder. Dr. D'Mello will collaborate with UC Berkeley researchers on how the brain responds to the meanings of thousands of different concepts. #ASD
2
7
303
Aging does not appear to follow the same molecular script for everyone, according to an 8-year study of more than 300 women. The findings in Science reveal that individual molecular trajectories of aging can diverge substantially from population-wide patterns and are shaped not only by genetics but also by factors such as circadian rhythm, seasonality, and environmental exposures. Learn more: scim.ag/4ikMUfG
15
121
8
494
58,216
utswCAND retweeted
Drs. Yanagisawa and Mignot received the 2026 Albert Lasker Award for Basic Medical Research for their pivotal work in the discovery of the orexin (hypocretin) system and its role in narcolepsy. Learn more in the Clinical Implications of Basic Research article “The Legacy of Orexin (Hypocretin) Research in Narcolepsy and Beyond” by Sebastiaan Overeem, MD, PhD, and Birgitte R. Kornum, PhD: nej.md/4A71sWP
1
121
8
331
35,636
Masashi Yanagisawa, M.D., Ph.D., is the recipient of a 2026 Lasker Award for discoveries that revealed how orexin regulates wakefulness and causes narcolepsy when absent. His groundbreaking work conducted at UTSW, is transforming the science of sleep. bit.ly/46dG700
19
1
59
4,188
📰 Breaking News: The U.S. Food and Drug Administration (FDA) has cleared the third Alzheimer's blood test for individuals experiencing signs or symptoms of cognitive impairment. This is the first blood test cleared for use in patients as young as 40. Read our full statement: bit.ly/3TZ8fBg.
1
47
8
88
7,797
The North Texas Alzheimer's Disease Research Center, now led by Pedro Rosa-Neto, M.D., Ph.D., is combining cutting-edge research, clinical trials, biomarker discovery, and community engagement, to shape the future of dementia care and research. @UTSWBrain bit.ly/3SdbvZ7
1
5
131
2026 Brain Summit Symposium | CE EVENT on NOV 7 We're back this year for a full day of stroke prevention & brain heath, optic neuritis, cerebellar ataxias, FND, anti-amyloid therapies, seizure management, & more. ​Take a look at our agenda: bit.ly/4x90HdS
2
10
338
The Parkinson’s Foundation funds innovative research across all areas of Parkinson’s disease, supporting studies on biology, brain circuitry and symptoms. 🔬 Meet some of our current investigators who are among the 775 researchers the Foundation has funded: Parkinson.org/advancing-rese…
1
3
16
2,439
An emerging body of work shows that glial cells act as leading architects of the neural extracellular matrix, which serves as a critical signaling hub for nerve synapses and neuronal circuits, according to a new Focus in @SciSignal. scim.ag/4grMx1o
4
79
2
342
43,565
Grateful for the continued support from the Parkinson’s Foundation. We have exciting synuclein data to share—stay tuned :)
Dr. Sarah Shahmoradian @ShahmoraLab received a @ParkinsonDotOrg Impact Award for research mapping how a novel PET tracer binds misfolded α-synuclein fibrils in #Parkinson’s brain tissue. Learn more: bit.ly/3XoPvt8
2
1
11
1,439
Proud to see our work featured! Grateful to my thoughtful and hardworking team, and to our wonderful collaborators who make this work possible. Stay tuned, we’re excited to share some of what we’ve been working on as preprints later this year! 🤠🔬🧠
Exploring the brain one neuron at a time, the @ShahmoraLab uses nanoscale imaging to uncover how neurodegenerative diseases like Parkinson’s and ALS begin and progress. Learn about the Shahmoradian Lab and its groundbreaking research: bit.ly/4wsg3Ju #UTSWMeetTheMinds
1
8
53
13,703
utswCAND retweeted
The US National Institutes of Health has proposed overhauling how it decides which research projects to fund, and how it reports the outcome of those deliberations. go.nature.com/4cNhwTc
4
24
2
42
40,245
We’re proud to have Sarah and the @ShahmoraLab at CAND, bringing a structural biology perspective to our work on neurodegeneration. Great to see the team featured by @UTSWScience! 🔬🧠 @UTSWBrain @biophysics_utsw @UTSWMedCenter
Exploring the brain one neuron at a time, the @ShahmoraLab uses nanoscale imaging to uncover how neurodegenerative diseases like Parkinson’s and ALS begin and progress. Learn about the Shahmoradian Lab and its groundbreaking research: bit.ly/4wsg3Ju #UTSWMeetTheMinds
1
5
475
Exploring the brain one neuron at a time, the @ShahmoraLab uses nanoscale imaging to uncover how neurodegenerative diseases like Parkinson’s and ALS begin and progress. Learn about the Shahmoradian Lab and its groundbreaking research: bit.ly/4wsg3Ju #UTSWMeetTheMinds
4
2
25
15,673
A new North Texas Alzheimer’s Disease Research Center based at #UTSW is accelerating efforts to better understand, detect, and treat Alzheimer’s and related dementias. Learn about the center’s mission and early progress. bit.ly/3SdbvZ7 #PatientCare
1
3
2
9
2,007
Drs. Brad Lega and Dr. Genevieve Konopka co-led research that shows deep brain stimulation strengthens and reshapes the building blocks of thoughts and memories. The findings could lead to more targeted and effective therapies for cognitive issues. bit.ly/4wp58jv
3
10
815